SMCT1 is downregulated during intestinal inflammation, and its expression is often silenced in aberrant crypt foci, colon adenomas, colon tumors, and colon cancer cell lines, suggesting that SMCT1 silencing is an early event in colon tumorigenesis. Here, SLC5A8 is linked to malignant colon neoplasm.